b'LymphoTrack Assay kits are designed for the identification of gene rearrangements in hematologic samples utilizing next-generation sequencing (NGS) technologies.These assays take advantage of the wealth and depth of NGS data generated with either the Illumina MiSeq or the Thermo Fisher Scientific Ion PGM and Ion S5 platforms. They offer significant improvements over conventional clonality testing methods, by providing the distribution of gene rearrangements, DNA sequences, the mutational status (IGH only), and the ability to track specific gene rearrangements all with the same workflow.Primers included in the master mixes are designed with Illumina adapters and indices (8 or 24 indices configurations for a total possible 24 or *48 unique indices [*FR1 only] per framework kits) or Thermo Fisher adapters and indices (12 indices per framework kits). By offering multiple kit configurations (8-or-24 indices for MiSeq, 12 for Ion S5/PGM), Invivoscribe further provides laboratories the ability to choose the optimal kit for their sample throughput and read-depth requirements. Testing costs can be reduced by sequencing in a single run, with the possibility to combine: a) samples with up to 48 different indices and b) amplicons from other LymphoTrack Assays.Research Use Only (RUO) assays are not for sale in Europe and other global markets where equivalent CE-IVD assays are available and registered with the appropriate regulatory agencies. For more information regarding the CE-marked LymphoTrack Dx Assays, please refer to the preceding pages.Invivoscribe 2020|35'